This Article Full Text Free Full Text (PDF) Free Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Guyton, K. Articles by Cook, J. Search for Related Content PubMed PubMed Citation Articles by Guyton, K. Articles by Cook, J.

(Journal of Leukocyte Biology. 2001;69:631-638.)
© 2001 by Society for Leukocyte Biology

Differential effects of 15-deoxy-^12,14-prostaglandin J₂ and a peroxisome proliferator-activated receptor agonist on macrophage activation

Kelly Guyton^*, Robert Bond, Chris Reilly, Gary Gilkeson, Perry Halushka^, and James Cook^¶

Departments of
^* Microbiology and Immunology,
Medicine,
Pharmacology, and
^¶ Physiology and Neuroscience, Medical University of South Carolina, Charleston; and
Department of Pharmacology and Physiology, University of South Carolina School of Medicine, Columbia

Correspondence: James A. Cook, Ph.D., Professor of Physiology/Neuroscience, Medical University of South Carolina, 167 Ashley Ave. Suite 607, Charleston, SC 29425. E-mail: cookja{at}musc.edu

Prostaglandin J₂ metabolite 15-deoxy-^12,14-prostaglandin J₂ (15-PGJ₂) appears to possess anti-inflammatory properties. Unlike other prostaglandins, it has no known plasma membrane receptor. Its effects have been thought to occur through activation of the nuclear peroxisome proliferator-activated receptor (PPAR), but 15-PGJ₂ may exhibit effects independent of PPAR. We hypothesized that 15-PGJ₂ modulates macrophage (M) mediator production by acting on cell signaling proteins upstream of PPAR. The effects of 15-PGJ₂ on bacterial endotoxin LPS-induced rat peritoneal M mediator production were compared with those of a specific PPAR agonist, BRL 49653 (BRL), and to the eicosanoids prostaglandin D₂ (PGD₂) and cicaprost (CICA, a prostacyclin analogue). 15-PGJ₂ inhibited LPS-induced production of NO, TNF-, and thromboxane B₂ (TxB₂). Equimolar concentrations of PGD₂ and CICA significantly inhibited LPS-stimulated TNF- but not NO, and CICA increased TxB₂ production. BRL inhibited LPS-induced NO, but augmented LPS-induced TNF- and TxB₂. 15-PGJ₂ also inhibited degradation of LPS-induced IB and phosphoactivation of ERK 1/2, but BRL had no significant effect on either protein. The cyclopentenone ring 2-cyclopenten-1-one also inhibited LPS-induced ERK 1/2 activation; however, neither 15-PGJ₂ nor the cyclopentenone inhibited PMA-induced ERK 1/2 activation. Inhibition of LPS-stimulated mediator production by 15-PGJ₂ differed from inhibition by PGD₂, CICA, and BRL. The ability of 15-PGJ₂ to inhibit LPS-induced M mediator production and cell signaling may occur in part through reactivity of its cyclopentenone ring.

Key Words: BRL 49653 • ERK 1/2 • IB • NO • TNF- • TxB₂

This article has been cited by other articles:

				G. Orasanu, O. Ziouzenkova, P. R. Devchand, V. Nehra, O. Hamdy, E. S. Horton, and J. Plutzky The Peroxisome Proliferator-Activated Receptor-{gamma} Agonist Pioglitazone Represses Inflammation in a Peroxisome Proliferator-Activated Receptor-{alpha}-Dependent Manner In Vitro and In Vivo in Mice J. Am. Coll. Cardiol., September 2, 2008; 52(10): 869 - 881. [Abstract] [Full Text] [PDF]

				H. Shiraishi, H. Yoshida, K. Saeki, Y. Miura, S. Watanabe, T. Ishizaki, M. Hashimoto, G. Takaesu, T. Kobayashi, and A. Yoshimura Prostaglandin E2 is a major soluble factor produced by stromal cells for preventing inflammatory cytokine production from dendritic cells Int. Immunol., September 1, 2008; 20(9): 1219 - 1229. [Abstract] [Full Text] [PDF]

				T. Tajima, T. Murata, K. Aritake, Y. Urade, H. Hirai, M. Nakamura, H. Ozaki, and M. Hori Lipopolysaccharide Induces Macrophage Migration via Prostaglandin D2 and Prostaglandin E2 J. Pharmacol. Exp. Ther., August 1, 2008; 326(2): 493 - 501. [Abstract] [Full Text] [PDF]

				H. Fan, B. Zingarelli, O. M. Peck, G. Teti, G. E. Tempel, P. V. Halushka, and J. A. Cook Lipopolysaccharide- and gram-positive bacteria-induced cellular inflammatory responses: role of heterotrimeric G{alpha}i proteins Am J Physiol Cell Physiol, August 1, 2005; 289(2): C293 - C301. [Abstract] [Full Text] [PDF]

				P. A. Ruiz, S. C. Kim, R. B. Sartor, and D. Haller 15-Deoxy-{Delta}12,14-prostaglandin J2-mediated ERK Signaling Inhibits Gram-negative Bacteria-induced RelA Phosphorylation and Interleukin-6 Gene Expression in Intestinal Epithelial Cells through Modulation of Protein Phosphatase 2A Activity J. Biol. Chem., August 20, 2004; 279(34): 36103 - 36111. [Abstract] [Full Text] [PDF]

				J. F. Maddox, A. C. Domzalski, R. A. Roth, and P. E. Ganey 15-Deoxy Prostaglandin J2 Enhances Allyl Alcohol-Induced Toxicity in Rat Hepatocytes Toxicol. Sci., February 1, 2004; 77(2): 290 - 298. [Abstract] [Full Text] [PDF]

				F. Bureau, C. Desmet, D. Melotte, F. Jaspar, C. Volanti, A. Vanderplasschen, P.-P. Pastoret, J. Piette, and P. Lekeux A Proinflammatory Role for the Cyclopentenone Prostaglandins at Low Micromolar Concentrations: Oxidative Stress-Induced Extracellular Signal-Regulated Kinase Activation Without NF-{kappa}B Inhibition J. Immunol., May 15, 2002; 168(10): 5318 - 5325. [Abstract] [Full Text] [PDF]

				D. G. Alleva, E. B Johnson, F. M Lio, S. A Boehme, P. J Conlon, and P. D. Crowe Regulation of murine macrophage proinflammatory and anti-inflammatory cytokines by ligands for peroxisome proliferator-activated receptor-{gamma}: counter-regulatory activity by IFN-{gamma} J. Leukoc. Biol., April 1, 2002; 71(4): 677 - 685. [Abstract] [Full Text] [PDF]